This medication is an enzyme (tissue plasminogen activator (tPA)), prescribed for heart attack, stroke, and pulmonary embolism. It helps to break down unwanted blood clots.
Contraindicated in patients with recent surgery or trauma, bleeding within the brain, uncontrolled high blood pressure, clotting defects, aneurysm or tumor in brain and active bleeding.
Adult: Acute massive pulmonary embolism- Total dose: 100 mg (not >1.5 mg/kg for patients weighing <65 kg). 10 mg as bolus, followed by infusion of the remainder dose over 2 hour.
Acute stroke: 0.9 mg/kg (not more than 90 mg) IV over 1 hour. The first 10% should be administered in 1 minute.
Heart attack: For patients weighing > 67 kg, 15 mg iv, followed by 50 mg over the next half an hour, and then 35 mg over the next 1 hour. The total dose of 100 mg may also be administered over 3 hours.
It comes as a solution for injection, to be injected by a healthcare provider into the vein.
• Potentially Fatal: Bleeding in the brain.
• Heart : Heart failure, abnormal heart rhythm and heart arrest.
• Central Nervous System : Cerebral edema (increased fluid content in the brain).
• Miscellaneous: Allergic reactions, nausea, vomiting, low blood pressure and fever.
Caution needed when administered with other drugs such as heparin and aspirin.
Injection: Store it at room temperature (<30°C) or under refrigeration.